TEKMIRA PHARMACEUTICALS Corp 4
4 · TEKMIRA PHARMACEUTICALS Corp · Filed Apr 2, 2015
Insider Transaction Report
Form 4
Murray Mark J.
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2015-03-30+180,000→ 180,000 totalExercise: $17.57From: 2016-03-30Exp: 2025-03-30→ Common shares (180,000 underlying)
Footnotes (1)
- [F1]The option vests in three equal installments beginning on the date so indicated and every 12 months thereafter, such grant vested in full at 3 years.